Key result
Percutaneous triple-valve balloon valvuloplasty was performed without complications at 22 weeks of gestation, achieving marked clinical improvement in a pregnant woman with triple-valve stenosis.
Case Report (n=1)
Percutaneous triple-valve balloon valvuloplasty is a feasible and effective alternative for pregnant women with triple-valve stenosis who wish to continue their pregnancy.
Should not yet change practice in pregnant patients with multivalve stenosis; extends sparse case-level evidence but remains hypothesis-generating.
A 22-yr-old pregnant woman with mitral, aortic, and tricuspid stenosis presented with accelerating dyspnea and shortness of breath at the end of her first trimester. She subsequently underwent percutaneous triple-valve balloon valvuloplasty at 22 weeks of gestation without complications and achieved marked clinical improvement. We conclude that percutaneous triple-valve balloon valvuloplasty represents an alternative treatment for mitral, aortic, and tricuspid stenosis in pregnant women with compromised cardiovascular status who do not wish to terminate their pregnancy.
No takes yet. Share an insight, caveat, or question.
Savas et al. (1991) conducted a case report in Mitral, aortic, and tricuspid stenosis in pregnancy (n=1). Percutaneous triple-valve balloon valvuloplasty was evaluated on Clinical improvement and complications. Percutaneous triple-valve balloon valvuloplasty was performed without complications at 22 weeks of gestation, achieving marked clinical improvement in a pregnant woman with triple-valve stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: